Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Azole-echinocandin Combination Therapy for Invasive Aspergillosis A Randomized Pragmatic Superiority Trial

NCT04876716 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT04876716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04876716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Azole-echinocandin Combination Therapy for Invasive Aspergillosis A Randomized Pragmatic Superiority Trial
Lead sponsor
Erasmus Medical Center
Phase
Phase 3
Overall status
Terminated
Start date
May 11, 2021
Completion date
May 1, 2024
Enrollment
66 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

invasive aspergillosis